Get started
Author

Yu Kato

Observed name: Y. Kato
ORCID: 0000-0003-1662-6983
Observed ORCID: 0000-0003-1662-6983
OpenAlex ID: A5039847095
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 · Ryosuke Hino, Kenji Kabashima, et al. · Cancer · 686
PDF
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
2015 · Takanori Kitamura, Bin-Zhi Qian, et al. · The Journal of Experimental Medicine · 659
PDF
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway
2019 · Yu Kato, Kimiyo Tabata, et al. · PLoS ONE · 466
PDF
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
2011 · Taku Okazaki, Il-mi Okazaki, et al. · The Journal of Experimental Medicine · 339
Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model
2018 · Takayuki Kimura, Yu Kato, et al. · Cancer Science · 335
PDF
PD-1 deficiency results in the development of fatal myocarditis in MRL mice
2010 · Jian Wang, Il-mi Okazaki, et al. · International Immunology · 268
Inhibition of FGFR Reactivates IFNγ Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies
2021 · Yusuke Adachi, Hiroshi Kamiyama, et al. · Cancer Research · 165
Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer
2018 · Takanori Kitamura, Dahlia Doughty-Shenton, et al. · Frontiers in Immunology · 152
PDF
Targeting of Tumor Cells for Human γδ T Cells by Nonpeptide Antigens
2001 · Yu Kato, Yoshimasa Tanaka, et al. · The Journal of Immunology · 146
PDF
Requirement of Species-Specific Interactions for the Activation of Human γδ T Cells by Pamidronate
2003 · Yu Kato, Yoshimasa Tanaka, et al. · The Journal of Immunology · 92
E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2021 · Kazuhiko Yamada, Yusaku Hori, et al. · Cancer Research · 71
In vivosubcellular resolution optical imaging in the lung reveals early metastatic proliferation and motility
2015 · David Entenberg, Carolina Rodriguez-Tirado, et al. · IntraVital · 61
PDF
Involvement of CD166 in the Activation of Human γδT Cells by Tumor Cells Sensitized with Nonpeptide Antigens
2006 · Yu Kato, Yoshimasa Tanaka, et al. · The Journal of Immunology · 60
Lenvatinib mesilate (LEN) enhanced antitumor activity of a PD-1 blockade agent by potentiating Th1 immune response
2016 · Y. Kato, X. Bao, et al. · Annals of Oncology · 45
PDF
Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway‐induced resistance to vascular endothelial growth factor receptor inhibitor
2014 · Takayuki Nakagawa, Tomohiro Matsushima, et al. · Cancer Science · 41
PDF
Long-term High-Resolution Intravital Microscopy in the Lung with a Vacuum Stabilized Imaging Window
2016 · Carolina Rodriguez-Tirado, Takanori Kitamura, et al. · Journal of Visualized Experiments · 35
Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2019 · Takanori Kitamura, Yu Kato, et al. · Cancer Immunology Research · 18
Abstract A92: Effects of lenvatinib on tumor-associated macrophages enhance antitumor activity of PD-1 signal inhibitors
2015 · Yu Kato, Kimiyo Tabata, et al. · Molecular Cancer Therapeutics · 16
Lenvatinib enhances antitumor immunity of anti-PD-1 antibody
2025 · Yu Kato · International Journal of Clinical Oncology · 13
PDF
Discovery of a potent and selective Axl inhibitor in preclinical model
2021 · Satoshi Inoue, Yoshinobu Yamane, et al. · Bioorganic & Medicinal Chemistry · 12
Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice
2009 · F. Jiang, T. Yoshida, et al. · International Immunology · 12
Abstract 4614: Upregulation of memory T cell population and enhancement of Th1 response by lenvatinib potentiate antitumor activity of PD-1 signaling blockade
2017 · Yu Kato · Cancer Research · 10
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
2024 · Jason W.-L. Eng, Yu Kato, et al. · Cancer Research Communications · 9
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine derivatives as novel selective Axl inhibitors
2021 · Satoshi Inoue, Yoshinobu Yamane, et al. · Bioorganic & Medicinal Chemistry Letters · 9
ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2022 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al. · Molecular Cancer Therapeutics · 5
Works count: 152
Citation count: 3,747
H-index: 17
I10-index: 22
Year
Topic
Type